{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "Synuclein",
        "Protein_Change": {
          "ref": "Wildtype",
          "alt": "",
          "position": ""
        },
        "variant_string_id": "Synuclein WT"
      },
      "functional_evidence_aim": "Determine the ability to transition between broken and extended helix conformations",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper discusses the ability of Synuclein protein to bind to synaptic vesicles and undergo structural reorganization from a dynamic ensemble to an extended helix upon binding. This conformation can convert into a broken helix state in the presence of small spheroidal detergent micelles. Membrane-bound conformations are likely involved in the function of the protein but may also play a role in aggregation and toxicity.",
          "judgment": "Yes",
          "reasoning": "The paper clearly describes the disease mechanism relevant to the functional assay, which is investigating the ability of Synuclein to transition between broken and extended helix conformations."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The authors use ESR measurements to study the distance and dynamics between spins, which is a common technique for studying protein conformation changes.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used (ESR measurements) effectively models or reflects the disease pathogenesis/mechanism defined in Step 1."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "sub_steps": [
            {
              "sub_step_name": "3a: Basic Controls and Replicates",
              "questions": [
                {
                  "question": "Were basic controls included for this assay? Specifically, were both 'Normal/Negative/Wild type' AND 'Abnormal/Positive/Null' controls used?",
                  "answer": "Yes"
                },
                {
                  "question": "Did the paper explicitly state that multiple replicates were used for the experiments?",
                  "answer": "No"
                }
              ],
              "judgment": "Proceed to Sub-step 3b."
            },
            {
              "sub_step_name": "3b: Accepted/Validated Assay",
              "questions": [
                {
                  "question": "Has the specific instance of the assay been broadly accepted historically (e.g., standard technique in the field) OR Previously validated in other studies (cited)?",
                  "answer": "Yes"
                }
              ],
              "judgment": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting."
            }
          ]
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_steps": [
            {
              "sub_step_name": "4a: Statistical Analyses",
              "question": "Are the statistical analyses in the paper sufficient to estimate or calculate OddsPath for the functional data for this variant?",
              "answer": "No"
            },
            {
              "sub_step_name": "4b: No OddsPath Calculation",
              "question": "How many total benign/pathogenic variant controls were used across the entire study (as applicable to this variant's assay)?",
              "answer": "10 or less"
            }
          ]
        }
      ],
      "functional_evidence_strength": "Max PS3_supporting / Max BS3_supporting"
    },
    {
      "variant_id": {
        "Gene": "Synuclein",
        "Protein_Change": {
          "ref": "Mutant A",
          "alt": "",
          "position": ""
        },
        "variant_string_id": "Synuclein Mutant A"
      },
      "functional_evidence_aim": "Determine the ability to transition between broken and extended helix conformations",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper discusses the ability of Synuclein protein to bind to synaptic vesicles and undergo structural reorganization from a dynamic ensemble to an extended helix upon binding. This conformation can convert into a broken helix state in the presence of small spheroidal detergent micelles. Membrane-bound conformations are likely involved in the function of the protein but may also play a role in aggregation and toxicity.",
          "judgment": "Yes",
          "reasoning": "The paper clearly describes the disease mechanism relevant to the functional assay, which is investigating the ability of Synuclein to transition between broken and extended helix conformations."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The authors use ESR measurements to study the distance and dynamics between spins, which is a common technique for studying protein conformation changes.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used (ESR measurements) effectively models or reflects the disease pathogenesis/mechanism defined in Step 1."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "sub_steps": [
            {
              "sub_step_name": "3a: Basic Controls and Replicates",
              "questions": [
                {
                  "question": "Were basic controls included for this assay? Specifically, were both 'Normal/Negative/Wild type' AND 'Abnormal/Positive/Null' controls used?",
                  "answer": "Yes"
                },
                {
                  "question": "Did the paper explicitly state that multiple replicates were used for the experiments?",
                  "answer": "No"
                }
              ],
              "judgment": "Proceed to Sub-step 3b."
            },
            {
              "sub_step_name": "3b: Accepted/Validated Assay",
              "questions": [
                {
                  "question": "Has the specific instance of the assay been broadly accepted historically (e.g., standard technique in the field) OR Previously validated in other studies (cited)?",
                  "answer": "Yes"
                }
              ],
              "judgment": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting."
            }
          ]
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_steps": [
            {
              "sub_step_name": "4a: Statistical Analyses",
              "question": "Are the statistical analyses in the paper sufficient to estimate or calculate OddsPath for the functional data for this variant?",
              "answer": "No"
            },
            {
              "sub_step_name": "4b: No OddsPath Calculation",
              "question": "How many total benign/pathogenic variant controls were used across the entire study (as applicable to this variant's assay)?",
              "answer": "10 or less"
            }
          ]
        }
      ],
      "functional_evidence_strength": "Max PS3_supporting / Max BS3_supporting"
    },
    {
      "variant_id": {
        "Gene": "Synuclein",
        "Protein_Change": {
          "ref": "Mutant B",
          "alt": "",
          "position": ""
        },
        "variant_string_id": "Synuclein Mutant B"
      },
      "functional_evidence_aim": "Determine the ability to transition between broken and extended helix conformations",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper discusses the ability of Synuclein protein to bind to synaptic vesicles and undergo structural reorganization from a dynamic ensemble to an extended helix upon binding. This conformation can convert into a broken helix state in the presence of small spheroidal detergent micelles. Membrane-bound conformations are likely involved in the function of the protein but may also play a role in aggregation and toxicity.",
          "judgment": "Yes",
          "reasoning": "The paper clearly describes the disease mechanism relevant to the functional assay, which is investigating the ability of Synuclein to transition between broken and extended helix conformations."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The authors use ESR measurements to study the distance and dynamics between spins, which is a common technique for studying protein conformation changes.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used (ESR measurements) effectively models or reflects the disease pathogenesis/mechanism defined in Step 1."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "sub_steps": [
            {
              "sub_step_name": "3a: Basic Controls and Replicates",
              "questions": [
                {
                  "question": "Were basic controls included for this assay? Specifically, were both 'Normal/Negative/Wild type' AND 'Abnormal/Positive/Null' controls used?",
                  "answer": "Yes"
                },
                {
                  "question": "Did the paper explicitly state that multiple replicates were used for the experiments?",
                  "answer": "No"
                }
              ],
              "judgment": "Proceed to Sub-step 3b."
            },
            {
              "sub_step_name": "3b: Accepted/Validated Assay",
              "questions": [
                {
                  "question": "Has the specific instance of the assay been broadly accepted historically (e.g., standard technique in the field) OR Previously validated in other studies (cited)?",
                  "answer": "Yes"
                }
              ],
              "judgment": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting."
            }
          ]
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_steps": [
            {
              "sub_step_name": "4a: Statistical Analyses",
              "question": "Are the statistical analyses in the paper sufficient to estimate or calculate OddsPath for the functional data for this variant?",
              "answer": "No"
            },
            {
              "sub_step_name": "4b: No OddsPath Calculation",
              "question": "How many total benign/pathogenic variant controls were used across the entire study (as applicable to this variant's assay)?",
              "answer": "10 or less"
            }
          ]
        }
      ],
      "functional_evidence_strength": "Max PS3_supporting / Max BS3_supporting"
    }
  ]
}